Antipsychotics Question Bank

Question 1 What is the drug of choice for treating persistent hiccups?

A) Methotrimeprazine
B) Perphenazine
C) Chlorpromazine
D) Fluphenazine
E) Loxapine

---

Question 2 Which receptor is primarily blocked by chlorpromazine?

A) Serotonin 5-HT2a
B) Alpha-1 adrenergic
C) Histamine H1
D) Dopamine D2
E) Muscarinic M1

---

Question 3 Which of the following is a common side effect of chlorpromazine?

A) Hypertension
B) Sedation
C) Weight loss
D) Hyperactivity
E) Insomnia

---

Question 4 For which conditions is chlorpromazine therapeutically used?

A) Depression and anxiety
B) Schizophrenia, psychosis, severe nausea and vomiting, hiccups, and dyspnea
C) Hypertension and diabetes
D) Asthma and COPD
E) Insomnia and chronic pain

---

Question 5 What is a common therapeutic use for methotrimeprazine?

A) Hypertension
B) Pain management in palliative care
C) Asthma
D) Epilepsy
E) Hyperthyroidism

---

Question 6 Which side effect is common to both chlorpromazine and methotrimeprazine?

A) Hypertension
B) Hyperactivity
C) Sedation
D) Weight loss
E) Insomnia

---

Question 7 Which receptor is primarily blocked by methotrimeprazine?

A) Serotonin 5-HT2a
B) Alpha-1 adrenergic
C) Histamine H1
D) Dopamine D2
E) Muscarinic M1

---

Question 8 What is a common therapeutic use for perphenazine?

A) Treating asthma
B) Treating schizophrenia and severe nausea and vomiting
C) Managing chronic pain
D) Reducing anxiety
E) Treating epilepsy

---

Question 9 Which class of drugs does chlorpromazine belong to?

A) SSRIs
B) SNRIs
C) Phenothiazines
D) Benzodiazepines
E) Beta-blockers

---

Question 11 What is the primary therapeutic use of clozapine?

A) Treating acute mania
B) Treating treatment-resistant schizophrenia
C) Managing depression
D) Controlling anxiety
E) Treating insomnia

---

Question 12 What is a significant side effect of clozapine that requires regular blood monitoring?

A) Hyperglycemia
B) Agranulocytosis
C) Hypertension
D) Hypothyroidism
E) QT prolongation

---

Question 13 Which antipsychotic is least likely to cause extrapyramidal symptoms (EPS) or tardive dyskinesia (TD)?

A) Risperidone
B) Quetiapine
C) Olanzapine
D) Clozapine
E) Ziprasidone

---

Question 14 Which antipsychotic is known for its use in the acute treatment of mania, schizophrenia, and bipolar disorder?

A) Clozapine
B) Olanzapine
C) Quetiapine
D) Risperidone
E) Paliperidone

---

Question 15 Which side effect is common to both clozapine and olanzapine?

A) Hyperprolactinemia
B) Hyperlipidemia
C) Oral hypoesthesia
D) Weight neutral
E) Intraoperative floppy iris syndrome

---

Question 16 Which antipsychotic has the least affinity for D2 receptors and is least likely to cause EPS?

A) Clozapine
B) Quetiapine
C) Risperidone
D) Olanzapine
E) Paliperidone

---

Question 17 Which antipsychotic is an active metabolite of risperidone and has low drug interaction potential due to not being metabolized in the liver?

A) Clozapine
B) Paliperidone
C) Olanzapine
D) Quetiapine
E) Ziprasidone

---

Question 18 Which antipsychotic is associated with the side effect of hyperprolactinemia and is less likely to cause dyslipidemia?

A) Clozapine
B) Olanzapine
C) Quetiapine
D) Risperidone
E) Ziprasidone

---

Question 19 Which antipsychotic is known for its potential efficacy in treating negative symptoms and depression due to its unique mechanism of partial agonism at 5HT1A and D2 receptors?

A) Clozapine
B) Aripiprazole
C) Olanzapine
D) Quetiapine
E) Paliperidone

---

Question 20 Which antipsychotic is weight neutral and has the least metabolic side effects?

A) Clozapine
B) Olanzapine
C) Aripiprazole
D) Quetiapine
E) Risperidone

---

Question 21 Which antipsychotic is available as a daily oral dose and has a prolonged-release injectable suspension?

A) Clozapine
B) Paliperidone
C) Olanzapine
D) Quetiapine
E) Ziprasidone

---

Question 22 Which antipsychotic can cause intraoperative floppy iris syndrome (IFIS) due to its alpha1 antagonist effect?

A) Clozapine
B) Paliperidone
C) Olanzapine
D) Quetiapine
E) Ziprasidone

---

Question 23 A 35-year-old male patient with schizophrenia has failed treatment with two other antipsychotic medications. The physician decides to start him on clozapine.

Question: What monitoring is required for this patient after initiating clozapine?

A) Weekly blood pressure checks
B) Monthly liver function tests
C) Weekly blood monitoring for the first 6 months
D) Daily ECG
E) Biannual kidney function tests

Follow-up Question 1: What is the primary mechanism of action of clozapine that contributes to its atypical antipsychotic effects?

A) Inhibits serotonin reuptake
B) Inhibits D2 and 5HT2 receptors
C) Enhances GABAergic transmission
D) Blocks NMDA receptors
E) Increases norepinephrine release

Follow-up Question 2: Which side effect of clozapine is least likely to occur?

A) Sedation
B) Agranulocytosis
C) Tardive dyskinesia
D) Weight gain
E) Hypersalivation

---

Question 24 A 45-year-old female patient is prescribed olanzapine for the acute treatment of mania associated with bipolar disorder. She reports significant weight gain and restlessness after a few weeks.

Question: What is a common side effect of olanzapine that could explain her symptoms?

A) Hyperprolactinemia
B) QT prolongation
C) Weight gain and restlessness
D) Hypersalivation
E) Agranulocytosis

Follow-up Question 1: What receptors does olanzapine primarily inhibit to exert its effects?

A) GABA and NMDA receptors
B) D2 and 5HT2 receptors
C) Alpha-1 and beta-2 receptors
D) Muscarinic and nicotinic receptors
E) Dopamine D1 and serotonin 5-HT1 receptors

Follow-up Question 2: What other side effect should the patient be monitored for while on olanzapine?

A) Hypotension
B) Hypoglycemia
C) Hyperlipidemia
D) Increased appetite
E) Hyperthyroidism

---

Question 25 A 28-year-old male patient with schizophrenia is started on quetiapine. He is concerned about the side effects, particularly those affecting his metabolic profile.

Question: What side effect should be discussed with the patient regarding quetiapine?

A) Agranulocytosis
B) Extrapyramidal symptoms (EPS)
C) Hyperlipidemia
D) Hyperprolactinemia
E) Tardive dyskinesia

Follow-up Question 1: What is the primary receptor binding profile of quetiapine?

A) High affinity for D2 receptors
B) High affinity for 5HT2a, H1, alpha1, and alpha2 receptors with low affinity for D2 receptors
C) High affinity for muscarinic receptors
D) High affinity for beta-adrenergic receptors
E) High affinity for NMDA receptors

Follow-up Question 2: Which side effect is least likely to occur with quetiapine compared to other antipsychotics?

A) Hyperlipidemia
B) Akathisia
C) Extrapyramidal symptoms (EPS)
D) Weight gain
E) Sedation

---

Question 26 A 52-year-old female patient with schizophrenia is prescribed risperidone. She reports experiencing dizziness and galactorrhea (milky discharge from the breasts) after a few weeks of treatment.

Question: What side effect of risperidone is she likely experiencing?

A) QT prolongation
B) Hyperprolactinemia
C) Agranulocytosis
D) Hypersalivation
E) Tardive dyskinesia

Follow-up Question 1: Which receptors does risperidone primarily inhibit to improve both positive and negative symptoms of schizophrenia?

A) GABA and NMDA receptors
B) D2 and 5HT2 receptors
C) Alpha-1 and beta-2 receptors
D) Muscarinic and nicotinic receptors
E) Dopamine D1 and serotonin 5-HT1 receptors

Follow-up Question 2: What other side effect should be monitored in patients taking risperidone?

A) Weight loss
B) Hyperglycemia
C) Hypotension
D) Weight gain
E) Hyperthyroidism

---

Question 27 A 45-year-old male patient on antipsychotic medication presents with elevated body temperature, severe muscle rigidity, rapid heart rate, and confusion. The physician suspects Neuroleptic Malignant Syndrome (NMS).

Question: What is the first step in managing this patient?

A) Increase the dose of the antipsychotic medication
B) Discontinue the antipsychotic medication
C) Administer a higher dose of benzodiazepines
D) Start a cooling blanket immediately
E) Administer beta-blockers

Follow-up Question 1: Which of the following medications can be used to reduce muscle rigidity in NMS?

A) Haloperidol
B) Bromocriptine
C) Amantadine
D) Dantrolene
E) Diazepam

Follow-up Question 2: What laboratory finding is commonly associated with NMS?

A) Elevated liver enzymes
B) Leukocytosis
C) Hypokalemia
D) Hyperglycemia
E) Low creatine kinase (CK)

---

Question 28 A 60-year-old female patient with Parkinson’s disease presents with hyperthermia, muscle rigidity, and altered mental status after suddenly stopping her dopaminergic medication.

Question: What is the likely diagnosis?

A) Serotonin syndrome
B) Malignant hyperthermia
C) Neuroleptic Malignant Syndrome (NMS)
D) Heat stroke
E) Thyroid storm

Follow-up Question 1: What medication can help counteract dopamine blockade in this patient?

A) Dantrolene
B) Bromocriptine
C) Amantadine
D) Diazepam
E) Haloperidol

Follow-up Question 2: Which of the following is NOT a symptom of NMS?

A) Elevated body temperature
B) Severe muscle rigidity
C) Rapid heart rate
D) Decreased blood pressure
E) Confusion

---

Question 29 A 50-year-old male patient with a history of schizophrenia presents with hyperthermia, severe muscle stiffness, sweating, and agitation. His recent laboratory tests show elevated creatine kinase (CK) and leukocytosis.

Question: Which of the following conditions is most consistent with his symptoms and laboratory findings?

A) Serotonin syndrome
B) Malignant hyperthermia
C) Neuroleptic Malignant Syndrome (NMS)
D) Thyroid storm
E) Heat stroke

Follow-up Question 1: What is a key distinguishing feature between NMS and serotonin syndrome?

A) Hyperthermia
B) Muscle rigidity
C) Autonomic dysfunction
D) History of antipsychotic medication use
E) Elevated creatine kinase (CK)

Follow-up Question 2: What is the role of benzodiazepines in the management of NMS?

A) To reduce muscle rigidity and agitation
B) To treat hyperthermia
C) To manage blood pressure
D) To treat metabolic acidosis
E) To reduce elevated creatine kinase (CK) levels

---

Question 30 What is the characteristic feature of acute dystonia associated with antipsychotic medications?

A) Inner restlessness and inability to stay still
B) Involuntary, sudden, severe muscle spasms, often in the neck, eyes, or jaw
C) Symptoms similar to Parkinson’s disease
D) Involuntary, repetitive movements, often involving the face, tongue, and extremities
E) Elevated body temperature and muscle rigidity

---

Question 31 What is the onset time for akathisia after initiating antipsychotic medication?

A) Hours to days
B) Days to weeks
C) Weeks to months
D) Months to years
E) Immediate

---

Question 32 Which medication is commonly used to manage acute dystonia caused by antipsychotic medications?

A) Propranolol
B) Lorazepam
C) Benztropine
D) Tetrabenazine
E) Procyclidine

---

Question 33 What are the symptoms of parkinsonism as an extrapyramidal side effect of antipsychotic medications?

A) Inner restlessness and an urgent need to move
B) Involuntary, repetitive movements of the face, tongue, and extremities
C) Tremor, rigidity, bradykinesia, and postural instability
D) Sudden, severe muscle spasms in the neck, eyes, or jaw
E) Severe muscle rigidity and hyperthermia

---

Question 34 Which of the following is a treatment option for managing tardive dyskinesia?

A) Increasing the dose of antipsychotic medication
B) Anticholinergic agents (e.g., benztropine)
C) Beta-blockers (e.g., propranolol)
D) VMAT2 inhibitors (e.g., tetrabenazine)
E) Benzodiazepines (e.g., lorazepam)

---

Question 35 What is the recommended management for akathisia induced by antipsychotic medications?

A) Anticholinergic agents
B) VMAT2 inhibitors
C) Beta-blockers (e.g., propranolol) and benzodiazepines (e.g., lorazepam)
D) Increasing the dose of antipsychotic medication
E) Discontinuing all medications

---

Question 36 How long after initiating antipsychotic medication does parkinsonism typically develop?

A) Hours to days
B) Days to weeks
C) Weeks to months
D) Months to years
E) Immediate

---

Question 37 Which type of movement disorder associated with antipsychotic medications may become irreversible if continued for a long time?

A) Acute dystonia
B) Akathisia
C) Parkinsonism
D) Tardive dyskinesia
E) Neuroleptic Malignant Syndrome (NMS)

---

Question 38 Which extrapyramidal side effect of antipsychotic medications is best managed by dose reduction or switching to a second-generation antipsychotic?

A) Acute dystonia
B) Akathisia
C) Parkinsonism
D) Tardive dyskinesia
E) Neuroleptic Malignant Syndrome (NMS)

---

Question 39 What is the characteristic onset time for tardive dyskinesia after using antipsychotic medications?

A) Hours to days
B) Days to weeks
C) Weeks to months
D) Months to years
E) Immediate

---

Question 40 A 55-year-old male patient with a history of schizophrenia is being treated with haloperidol. He reports significant sedation and finds it difficult to stay awake during the day.

Question: What is a common side effect of haloperidol that could explain his symptoms?

A) Insomnia
B) Hyperactivity
C) Sedation
D) Weight loss
E) Increased appetite

---

Question 41 A 45-year-old female patient with schizophrenia and a sedentary lifestyle is being considered for antipsychotic treatment. The physician wants to minimize the risk of metabolic side effects.

Question: Which antipsychotic is most appropriate for this patient?

A) Olanzapine
B) Quetiapine
C) Aripiprazole
D) Clozapine
E) Risperidone

Follow-up Question 1: What is a key benefit of aripiprazole in treating psychosis?

A) High risk of EPS
B) High metabolic side effects
C) Weight neutrality and low risk of metabolic side effects
D) Significant sedation
E) High anticholinergic burden

Follow-up Question 2: What is the primary mechanism of action of aripiprazole?

A) Full agonist at D2 receptors
B) Partial agonist at 5HT1a and D2 receptors, antagonist at 5HT2A receptors
C) Inhibits serotonin reuptake
D) Blocks NMDA receptors
E) Enhances GABAergic transmission

---

Question 42 A 60-year-old male patient with schizophrenia and type 2 diabetes requires an antipsychotic medication. The physician aims to avoid worsening his metabolic condition.

Question: Which antipsychotic should be avoided in this patient?

A) Aripiprazole
B) Risperidone
C) Olanzapine
D) Ziprasidone
E) Lurasidone

Follow-up Question 1: What is a significant metabolic side effect of olanzapine?

A) Weight loss
B) Hypoglycemia
C) Hyperlipidemia
D) Hyperthyroidism
E) Hypertension

Follow-up Question 2: Which antipsychotic would be a better option for a patient with schizophrenia and diabetes?

A) Aripiprazole
B) Olanzapine
C) Clozapine
D) Quetiapine
E) Haloperidol

---

Question 43 A 38-year-old female patient with schizophrenia has developed akathisia after starting an antipsychotic medication. She reports severe inner restlessness and an urgent need to move.

Question: What is the most appropriate treatment for her akathisia?

A) Increase the dose of the antipsychotic medication
B) Discontinue all antipsychotic medications
C) Prescribe beta-blockers (e.g., propranolol) and benzodiazepines (e.g., lorazepam)
D) Use anticholinergic agents (e.g., benztropine)
E) Administer a higher dose of the current antipsychotic

Follow-up Question 1: Which of the following is not effective in treating akathisia?

A) Propranolol
B) Benztropine
C) Lorazepam
D) Dose reduction of the antipsychotic
E) Switching to a different antipsychotic

Follow-up Question 2: What is a key symptom of akathisia?

A) Tremor
B) Muscle rigidity
C) Inner restlessness and inability to stay still
D) Involuntary, repetitive movements
E) Severe muscle spasms

---

Question 44 A 45-year-old male patient with long-standing paranoia is diagnosed with schizophrenia.

Question: What is a common symptom of schizophrenia related to his condition?

A) Hyperactivity
B) Long-standing paranoia
C) Insomnia
D) Increased appetite
E) Weight gain

Follow-up Question 1: What is the primary treatment goal for schizophrenia?

A) Weight reduction
B) Enhancing cognitive function
C) Reducing positive and negative symptoms
D) Managing hypertension
E) Treating hyperlipidemia

Follow-up Question 2: Which antipsychotic is commonly used as the first-line treatment for schizophrenia?

A) Clozapine
B) Olanzapine
C) Risperidone
D) Haloperidol
E) Quetiapine